Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Pyruvate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyruvate SCHEMBL3635702 | 1.00 | CA4 (1.00) | — | |
| Pyruvate SCHEMBL1332722 | 1.00 | — | — | |
| Pyruvate SCHEMBL28324563 | 1.00 | CA4 (1.00) | — | |
| Pyruvate SCHEMBL1333219 | 1.00 | — | — | |
| Pyruvate SCHEMBL1332812 | 1.00 | — | — | |
| Pyruvate SCHEMBL1332703 | 1.00 | — | — | |
| Pyruvate SCHEMBL1332958 | 1.00 | — | — | |
| Pyruvate SCHEMBL1331761 | 1.00 | — | — | |
| Pyruvate SCHEMBL15541131 | 0.96 | — | — | |
| Pyruvate SCHEMBL20481652 | 0.96 | CA4 (0.92) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 115156 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122081213-A | Preparation method and application of enucleated mesenchymal stem cells for in-situ release of apoptotic bodies | — | 2026-05-26 | — | — | CN | claimed |
| CN-122081205-A | Fertilization culture solution and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122081206-A | Preparation method of articular cartilage organoids, biological ink for encapsulating articular cartilage organoids, preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122080382-A | Isosorbide type polycarbonate and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-120505386-B | Method for modifying protein in open environment and protein modifier | PEKING UNIVERSITY SCHOOL OF STOMATOLOGY (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122081116-A | Culture medium for high-density culture of mycoplasma hyorhinis and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-121379932-B | Culture medium for high-density serum-free suspension culture of BHK-21 cells and application thereof | Zhongsheng tianxinhe (Wuxi) Biotechnology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122081234-A | Low-serum MSB1 suspension medium and chicken infectious anemia virus inactivated vaccine | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026104367-A1 | SALMONIDAE CELL DERIVATION AND MAINTENANCE | Roslin Technologies Limited (GB) | 2026-05-21 | — | — | WO | claimed |
| WO-2026097260-A1 | CHICKEN SERUM-FREE CULTURE MEDIUM FOR PROMOTING PROLIFERATION OF CHICKEN PRIMORDIAL GERM CELLS AND USE THEREOF | 扬州大学 | 2026-05-15 | — | — | WO | claimed |
| EP-0110609-A1 | Sterilizing treatment with hydrogen peroxide and neutralization of residual amounts thereof | THE COOPER COMPANIES, INC. (formerly called CooperVision, Inc.) (US) | 1984-06-13 | — | — | EP | claimed |
| US-4411993-A | ANTITUMOR AND -CARCINOGENIC AGENTS | IMMUNEX CORPORATION | 1983-10-25 | — | — | US | claimed |
| US-4407945-A | Constitutive production of interleukin 2 by a T cell hybridoma | IMMUNEX CORPORATION (US) | 1983-10-04 | — | — | US | claimed |
| EP-0076647-A2 | Culture media for cells originating from the immune system | HANA Biologics Incorporated (US) | 1983-04-13 | — | — | EP | claimed |
| EP-0019054-B1 | NUTRIENT MEDIUM AND ITS USE IN TESTING ANTIMICROBIAL AGENTS | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-05-05 | — | — | EP | claimed |
| US-4275154-A | Nutrient medium | HOFFMANN-LA ROCHE INC. (US) | 1981-06-23 | — | — | US | claimed |
| EP-0019054-A1 | Nutrient medium and its use in testing antimicrobial agents | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1980-11-26 | — | — | EP | claimed |
| US-4154962-A | Synthesis of hydratropic acid and some of its alkyl derivatives | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 1979-05-15 | — | — | US | claimed |
| US-4049494-A | Vaccine production process | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1977-09-20 | — | — | US | claimed |
| US-4042733-A | Forming solid, adhesive-free composite of membrane filters and cellulosic cardboard | BOEHRINGER INGELHEIM GMBH (DT) | 1977-08-16 | — | — | US | claimed |